StockMarketWire.com - Allergy Therapeutics, the fully integrated specialty pharmaceutical group specialising in allergy vaccines, will issue its preliminary results for the year ended 30 June on 28 September.


At 9:15am: [LON:AGY] Allergy Therapeutics PLC share price was +0.25p at 29.25p



Story provided by StockMarketWire.com